about
Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptorsPharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonistPharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtypeIdentification of two subtypes in the rat type I angiotensin II receptorAT(2) receptors mediate tonic renal medullary vasoconstriction in renovascular hypertension.Role of AT1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbitAngiotensin II receptor blockade limits glomerular injury in rats with reduced renal massMechanisms of angiotensin II chronotropic effect in anaesthetized dogs.Nonpeptide angiotensin AT1 and AT2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats.Angiotensin type 2 receptors in the intermediolateral cell column of the spinal cord: negative regulation of sympathetic nerve activity and blood pressure.Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection?Identification of a negative cis-regulatory element and trans-acting protein that inhibit transcription of the angiotensin II type 1a receptor gene.The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.Macrophages in neuroinflammation: role of the renin-angiotensin-system.The angiotensin II receptor (Agtr1a): functional regulatory polymorphisms in a locus genetically linked to blood pressure variation in the mouse.New avenues in antihypertensive drug treatment.Angiotensin II receptor antagonists: the prototype losartan.The conformational change responsible for AT1 receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII.The neuronal role of angiotensin II in thirst, sodium appetite, cognition and memory.Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells.Activation of AT1 angiotensin receptors induces DNA synthesis in a rat intestinal epithelial (RIE-1) cell line.Comparative pharmacology of recombinant rat AT1A, AT1B and human AT1 receptors expressed by transfected COS-M6 cells.Molecular cloning of the canine angiotensin II receptor. An AT1-like receptor with reduced affinity for DuP753.Modulation of Na-H exchange activity by angiotensin II in opossum kidney cells.The angiotensin AT2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells.Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta.Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells. Evidence for involvement of the proteasome pathway.Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atriaBMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cellsThe kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor.Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aortaControlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro ratsInhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action.Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.Regional haemodynamic effects of angiotensin II (3-8) in conscious rats.At receptor inhibition affects the noradrenaline sensitivity in isolated portal vein of normotensive rat.Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
P2860
Q28343259-84FBDAFD-A3DD-45BF-8C5A-CB6C4D9A5D63Q28367875-8816FA6B-4018-4FA8-85F7-5F5D4DCA5427Q28378367-F7206759-A175-4D7B-BCBE-76DAF04FB27CQ28645955-5B948C8E-E8E7-4F14-B03A-18F585C0677FQ33211280-2B075E86-0DBB-42AA-B311-C6388B6AFA77Q33895857-2B7373D6-9BAF-4C6C-A3C1-196953DD1445Q35821338-0AEB0056-E0EC-46C4-8C27-E729653E0535Q35872250-5FD746D7-453C-4CAA-BC5E-EEEE2DC7410FQ36777180-71F8850B-3D2C-44AA-A3EA-67CE37B330A4Q37290038-2A50B318-9948-440B-9CE9-1534099E86D3Q37800362-3D7E2362-F25A-4C7B-94F5-EB45EB5F51FFQ38290362-4137800B-8E86-4546-A862-AE7627E40E3CQ38299038-70D74F04-F7E6-477C-9B10-F0E5CEDA4160Q38965333-425C9C40-B5F7-4B79-8276-28A80B0432B8Q40655015-C1835B78-7F01-4B31-8F6B-29C7A220F9B3Q40794690-AF7FBCA1-9D29-4BED-898C-4559640869E5Q41102136-B04F6F06-425E-4CD2-8B31-8967C8DA8448Q41127850-2B79D3BE-119B-493C-933D-8DEC4C3D51C7Q41220618-76C2BDF7-1019-4FC0-A0B9-4F9EB0A8A8B2Q41282103-F9EFA05B-74AA-490A-A3F3-A6C6A4AC8F8FQ41442193-91ECD1C2-D699-4B24-9BFE-C6BB1124719AQ41470927-B35911DE-B76E-47CC-B649-9FAE56E4878FQ41473043-BAFD164B-B605-45E1-88C4-A2D6CA801021Q41592469-3A9BDA04-E083-4646-8424-9BD288974895Q41603502-8A568BAF-0889-4017-BC6E-D39B24F1FB46Q41874040-554A40F4-5C09-4AD8-893E-1827923B565EQ41928419-16B72AF6-5FBF-46DB-9092-763607BFC199Q41952244-A6A349C0-49BE-4900-88F0-C984AABDDD41Q42034040-CB37117D-A1EA-4CA4-9CDD-DA939940C76EQ42039693-EE233634-8EF8-4982-9D54-39CA56340E33Q42138836-A38ED60C-6543-431E-A05A-E1919D389E13Q42178094-88DF0465-EC34-4FA7-BFDA-F53481303870Q42554480-025DD675-7BEF-45CB-AB68-B9EDCF6F3E7AQ42714643-B183851D-F432-4F9B-A1D9-8355555C4388Q42716498-7F663718-5BA0-4601-A088-2E3D1BF9347DQ42717791-0F7C4D26-351C-4D22-A3EF-0B7BF6B67757Q42830674-034306B9-D046-4528-835F-4E40A0FE9F58Q42920906-3B2FCF4F-AF2B-49DC-A9AA-3D59BAC9879DQ43599143-4C9D0E23-D98D-4A61-948E-CDB640674F56Q43684605-1F4CFFDD-0DA4-4F10-A88B-4BCA4B4E7E3C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonpeptide angiotensin II receptor antagonists.
@en
type
label
Nonpeptide angiotensin II receptor antagonists.
@en
prefLabel
Nonpeptide angiotensin II receptor antagonists.
@en
P2093
P1476
Nonpeptide angiotensin II receptor antagonists.
@en
P2093
P356
10.1016/0165-6147(91)90498-H
P577
1991-02-01T00:00:00Z